Remedium Lifecare posts consolidated Q2 FY26 net profit higher at Rs. 8.62 Cr
Consolidated revenue from operations stood at Rs. 111.05 crore
Consolidated revenue from operations stood at Rs. 111.05 crore
This is the first drug to receive a recommendation for this preventative indication in the European Union
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
The observations are procedural in nature and will be responded to within the stipulated time
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
The partnership aims to develop novel, selective small molecules targeting TDP-43 pathology
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
Subscribe To Our Newsletter & Stay Updated